Encephalitis after secondary smallpox vaccination

Clinical Infectious Diseases

Volumn 48, Issue 1, 2009, Pages

  Melekhin, Vlada V ^a   Karem, Kevin L ^b   Damon, Inger K ^b   Bloch, Karen C ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GADOLINIUM; HEPATITIS A VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; PHENYTOIN; SMALLPOX VACCINE;

ADULT; ANAMNESIS; ARTICLE; BRAIN REGION; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID PRESSURE; CLINICAL FEATURE; DIAGNOSTIC TEST; EHRLICHIA CHAFFEENSIS; ELECTROENCEPHALOGRAM; ENCEPHALITIS; ENTEROVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPTIC DISCHARGE; EPSTEIN BARR VIRUS; GLASGOW COMA SCALE; HERPES SIMPLEX; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOFLUORESCENCE TEST; LEUKOCYTE COUNT; LUMBAR PUNCTURE; LYMPHOCYTE; MALE; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE IMAGING; PARVOVIRUS; PHOTOPHOBIA; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; POSTVACCINAL ENCEPHALITIS; PRIORITY JOURNAL; REVACCINATION; RICKETTSIA RICKETTSII; SEROLOGY; VACCINIA VIRUS;

ADULT; ANTIBODIES, VIRAL; ENCEPHALITIS; HUMANS; IMMUNIZATION, SECONDARY; MALE; SMALLPOX VACCINE; VACCINIA;

EID: 57749091996     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/595555     Document Type: Article

References (12)

1. Sejvar JJ, Labutta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane JM. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA 2005; 294:2744-50.
2. Aragon TJ, Ulrich S, Fernyak S, Rutherford GW. Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968. BMC Public Health 2003;3:26.
3. Gurvich EB, Vilesova IS. Vaccinia virus in postvaccinal encephalitis. Acta Virol 1983; 27:154-9.
4. Miravalle A, Roos KL. Encephalitis complicating smallpox vaccination. Arch Neurol 2003; 60:925-8.
5. Neff J, Modlin J, Birkhead GS, et al. Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the Advisory Committee on Immunization Practices and the Armed Forces Epidemiological Board. Clin Infect Dis 2008; 46(Suppl 3):S258-70.
6. Karem KL, Reynolds M, Braden Z, et al. Characterization of acutephase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol 2005; 12:867-72.
7. Sejvar JJ, Chowdary Y, Schomogyi M, et al. Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis 2004; 190:1833-40.
8. Sejvar J, Boneva R, Lane JM, Iskander J. Severe headaches following smallpox vaccination. Headache 2005; 45:87-8.
9. Smith GL, Symons JA, Alcami A. Immune modulation by proteins secreted from cells infected by vaccinia virus. Arch Virol 1999; 15(Suppl):111-29.
10. Symons JA, Tscharke DC, Price N, Smith GL. A study of the vaccinia virus interferon-γ receptor and its contribution to virus virulence. J Gen Virol 2002; 83:1953-64.
11. Humlová Z, Vokurka M, Esteban M, Melková Z. Vaccinia virus induces apoptosis of infected macrophages. J Gen Virol 2002; 83:2821-32.
12. Casey C, Vellozzi C, Mootrey GT, et al. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep 2006; 55(RR-1):1-16.